Usage of chlorogenic acid in preparation of drug for treating oligodendroglioma

Abstract

The invention provides a usage of chlorogenic acid in the preparation of a drug for treating oligodendroglioma. The chlorogenic acid has the efficacy of inhibiting oligodendroglioma, and can inhibit the growth of brain tumor stem cells, replace part of radiotherapy and chemotherapy and reduce the discomfort of a patient due to radiotherapy and chemotherapy. Novel drug therapy means and selection for treating oligodendroglioma are provided by the invention.

Description

technical field [0001] The invention relates to the use of chlorogenic acid in preparing medicine for treating oligodendroglioma. Background technique [0002] In recent years, the mortality rate of cancer has leapt to the top of various causes of death in China. It may be related to smoking, population aging, and the process of industrialization. The incidence of common tumors such as esophageal cancer, gastric cancer, and liver cancer in traditional poverty-stricken areas is still high, while multiple tumors such as lung cancer, breast cancer, and colon cancer in rich countries have increased rapidly. The latest survey shows that the incidence of brain tumors in developed countries continues to rise, and the disease also shows a clear trend of younger age, gradually approaching young people under the age of 40, and has become one of the important tumors that threaten children's health. According to the statistics of the United States, among the causes of cancer death amo...

AI Technical Summary

Problems solved by technology

[0010] In summary, the effects of chlorogenic acid on brain tumors disclosed in the existing literature are limited to glioblastoma in astrocytoma (the mechanism of action is described), and there is no chlorogenic acid to treat brain glioblastoma

Images